Daniel J. Wattier
Amministratore Delegato presso Valocor Therapeutics, Inc.
Provenienza dei contatti di primo grado di Daniel J. Wattier
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada.
6
| Holding Company | Biotechnology | 6 |
Network Immunology, Inc.
 Network Immunology, Inc. Miscellaneous Commercial ServicesCommercial Services Network Immunology, Inc. developing novel immuno-therapies based on immune network theory services. It is a preclinical stage biotechnology company, which focuses on discovering and developing novel treatments for autoimmune conditions and infectious diseases. The company was founded by George Hoffmann and Geoffrey W. Hoffmann in 2003 and is headquartered in Vancouver, Canada.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Valocor Therapeutics, Inc.
 Valocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Valocor Therapeutics is a clinical-stage, privately-held company dedicated to developing innovative treatments for major unmet needs in dermatology. The company's portfolio of dermatology therapeutics includes Lemuteporfin, a potent and selective topical photodynamic therapy for moderate to severe acne and a portfolio of novel, topical small molecule therapeutics targeting acne, sebaceous gland hyperactivity, skin pigmentation disorders and inflammatory skin diseases. Valocor Therapeutics is headquartered in Vancouver, British Columbia. Although many common yet serious skin conditions have unsatisfactory treatment options, dermatology has in recent years attracted limited research resources and investment. As a result, a sparse pipeline and a lack of true scientific innovation have been the dominant themes of this field for the last twenty years. During this same period, technological advances have produced new research techniques that have greatly expanded its ability to study disease processes and establish new effective therapeutic strategies. Much of this innovative research has been applied to the fields such as oncology, autoimmunity, and ocular diseases. Valocor is applying current biotechnology techniques to develop breakthrough therapies for major dermatological diseases, where prevalent conditions, minimal competition and important medical needs exist.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Daniel J. Wattier tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| SIERRA WIRELESS, INC. | Electronic Production Equipment | Director of Finance/CFO | |
Pender Private Investments Inc
 Pender Private Investments Inc Investment ManagersFinance Working Opportunity Fund (EVCC) Ltd seeks investment opportunities in companies located in British Columbia (Canada). The fund targets companies operating in the fields of information technology, life sciences, and clean technologies. It provides financing for early and later stage capital requirements. | Investment Managers | Director/Board Member | |
| INMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Corporate Officer/Principal | |
| GLOBAL GAMING TECHNOLOGIES CORP. | Financial Conglomerates | Director of Finance/CFO | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chief Operating Officer | |
| University of Oxford | College/University | Doctorate Degree | |
| University of London | College/University | Doctorate Degree | |
| University of Alberta | College/University | Doctorate Degree | |
| University of British Columbia | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Princeton University | College/University | Doctorate Degree | |
| University of Victoria | College/University | Undergraduate Degree | |
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ecotrust Canada
 Ecotrust Canada Miscellaneous Commercial ServicesCommercial Services Ecotrust Canada is an organization that collaborates with rural, remote, and indigenous communities to create a sustainable economy that supports a healthy and resilient natural environment, as well as sustainable and abundant energy, food, and housing. The private company is based in Vancouver, Canada. The Canadian company also aims to promote prosperous and meaningful livelihoods, vibrant cultures, and inclusive societies. The company was founded in 1994 by Jacqueline L. Koerner, and the CEO is Chuck Rumsey. | Miscellaneous Commercial Services | Director/Board Member | |
| LIGNOL ENERGY CORPORATION | Chemicals: Specialty | Director of Finance/CFO | |
Order of Canada
 Order of Canada Miscellaneous Commercial ServicesCommercial Services Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Alberta Bar Association | Corporate Officer/Principal | ||
British Columbia Bar Association
 British Columbia Bar Association Miscellaneous Commercial ServicesCommercial Services British Columbia Bar Association Operates as a law firm association to provide legal services. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Vancouver Opera Association
 Vancouver Opera Association Movies/EntertainmentConsumer Services Vancouver Opera Association operates as a performing arts organization. It strives to be the destination performing arts organization that entertains, stimulates and enriches British Columbians, driven by programming that redefines ''opera'' and revolutionizes its accessibility and community value. The company was founded in 1958 and is headquartered in Vancouver, Canada. | Movies/Entertainment | Director/Board Member | |
| BIOASIS TECHNOLOGIES INC. | Biotechnology | Director/Board Member | |
Biovail Laboratories International SRL
 Biovail Laboratories International SRL Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Biovail Laboratories International SRL develops, manufactures, and sells pharmaceutical products. The company is based in Saint Michael, Barbados. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
viDA Therapeutics, Inc.
 viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Canadian Federation of Biological Societies | President | ||
| Emerita, Inc. | Director/Board Member | ||
The Chartered Professional Accountants of British Columbia
 The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services The Chartered Professional Accountants of British Columbia is an association of accountants based in Vancouver, Canada. and has subsidiaries in Australia. The Canadian company operates as an association of accountants. The CEO of the private company is Lori Mathison. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AiVita Biomedical, Inc.
 AiVita Biomedical, Inc. Pharmaceuticals: MajorHealth Technology AiVita Biomedical, Inc. operates as a therapeutic development company which focuses on regenerative and curative medicines. Its products include Provoque facial serum and Provoque eye complex. The company was founded by Hans S. Keirstead in 2016 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
Phoenix Molecular Designs Ltd.
 Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| Proactive Immune Sciences Corp. | Director of Finance/CFO | ||
GABA Therapeutics, Inc.
 GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MRM Proteomics, Inc.
 MRM Proteomics, Inc. BiotechnologyHealth Technology MRM Proteomics, Inc. provides proteomics services. Its products include PeptiQuant, protein quant and quality control kits. The firm offers PeptiQuant protein quantitation, protein characterization and tissue imaging services. The company was founded in 2010 and is headquartered in Montreal, Canada. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Canada | 37 |
| Stati Uniti | 10 |
| Regno Unito | 4 |
| Finlandia | 2 |
| Barbados | 2 |
Settori
| Health Technology | 28 |
| Consumer Services | 8 |
| Commercial Services | 7 |
| Finance | 3 |
| Electronic Technology | 2 |
Posizioni
| Director/Board Member | 42 |
| Corporate Officer/Principal | 15 |
| Director of Finance/CFO | 11 |
| Chief Tech/Sci/R&D Officer | 9 |
| Founder | 8 |
Contatti più connessi
- Borsa valori
- Insiders
- Daniel J. Wattier
- Connessioni Società
